文献速递精神分裂症与精神病性障碍

酸性鞘磷脂酶活性提示精神分裂症的新型抗精神病药物治疗策略

Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia.
PubMed 文献 · Mol Psychiatry · 2025-01-17

研究分析精神分裂症患者基因多态性与脑基因表达,发现SMPD1和SMPD3基因关联;在苯丙胺超敏化大鼠精神病模型中,前额叶皮质酸性鞘磷脂酶(ASM)活性局部升高,ASM抑制剂KARI201可逆转精神病样行为且不引起运动下降和认知损害,而氟哌啶醇治疗有效但导致运动下降和认知损害。

要点

  • 精神分裂症患者SMPD1和SMPD3基因多态性及脑基因表达与疾病相关。
  • 苯丙胺超敏化大鼠前额叶皮质ASM活性局部升高,氟哌啶醇可逆转行为症状及ASM活性。
  • ASM抑制剂KARI201逆转精神病样行为且不引起运动下降和认知损害。

核心结论

  • 研究数据为精神分裂症潜在致病机制提供新见解,并提示一种副作用减少的新型药物治疗策略。

研究设计与样本

  • 分析精神分裂症患者人类基因多态性和脑基因表达。
  • 使用苯丙胺超敏化大鼠精神病模型进行短期氟哌啶醇治疗和ASM抑制剂KARI201干预。
  • 进行鞘脂组学分析和前额叶皮质RNA测序分析。

主要发现

  • 精神分裂症患者中SMPD1和SMPD3基因(分别编码酸性鞘磷脂酶ASM和中性鞘磷脂酶-2 NSM)存在关联。
  • 苯丙胺超敏化大鼠前额叶皮质ASM活性局部升高,短期氟哌啶醇治疗逆转行为症状和ASM活性。
  • 鞘脂组学分析证实精神病状态期间前额叶皮质神经酰胺代谢改变。
  • ASM抑制剂KARI201逆转精神病样行为及鞘脂组相关变化。
  • 有效的氟哌啶醇治疗导致运动下降和认知损害,而KARI201未导致。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Schizophrenia is a chronic and severe mental disorder. It is currently treated with antipsychotic drugs (APD). However, APD's work only in a limited number of patients and may have cognition impairing side effects. A growing body of evidence points out the potential involvement of abnormal sphingolipid metabolism in the pathophysiology of schizophrenia. Here, an analysis of human gene polymorphisms and brain gene expression in schizophrenia patients identified an association of SMPD1 and SMPD3 genes coding for acid- (ASM) and neutral sphingomyelinase-2 (NSM). In a rat model of psychosis using amphetamine hypersensitization, we found a locally restricted increase of ASM activity in the prefrontal cortex (PFC). Short-term haloperidol (HAL) treatment reversed behavioral symptoms and the ASM activity. A sphingolipidomic analysis confirmed an altered ceramide metabolism in the PFC during psychosis. Targeting enhanced ASM activity in a psychotic-like state with the ASM inhibitor KARI201 reversed psychotic like behavior and associated changes in the sphingolipidome. While effective HAL treatment led to locomotor decline and cognitive impairments, KARI201 did not. An RNA sequencing analysis of the PFC suggested a dysregulation of numerous schizophrenia related genes including Olig1, Fgfr1, Gpr17, Gna12, Abca2, Sox1, Dpm2, and Rab2a in the rat model of psychosis. HAL and KARI201 antipsychotic effects were associated with targeting expression of other schizophrenia associated genes like Col6a3, Slc22a8, and Bmal1, or Nr2f6a, respectively, but none affecting expression of sphingolipid regulating genes. Our data provide new insight into a potentially pathogenic mechanism of schizophrenia and suggest a new pharmaco-treatment strategy with reduced side effects.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chestnykh D, Mühle C, Schumacher F, et al. Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia. Mol Psychiatry. 2025. PMID: 39825014. doi:10.1038/s41380-025-02893-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。